isf 2405 has been researched along with procainamide in 1 studies
| Studies (isf 2405) | Trials (isf 2405) | Recent Studies (post-2010) (isf 2405) | Studies (procainamide) | Trials (procainamide) | Recent Studies (post-2010) (procainamide) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 3,612 | 174 | 122 |
| Protein | Taxonomy | isf 2405 (IC50) | procainamide (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 3.9 | |
| Sterol O-acyltransferase 1 | Rattus norvegicus (Norway rat) | 1 | |
| Acetylcholinesterase | Homo sapiens (human) | 1 | |
| Acetylcholinesterase | Bos taurus (cattle) | 0.5 | |
| Sterol O-acyltransferase 1 | Homo sapiens (human) | 1 | |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | 7.35 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, M; Dahlbäck, B; Englund, G; Hanson, A | 1 |
1 other study(ies) available for isf 2405 and procainamide
| Article | Year |
|---|---|
Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
Topics: Antihypertensive Agents; Complement C3; Complement C4; Dihydralazine; Humans; Hydralazine; Hydroxylamine; Hydroxylamines; Procainamide; Pyridazines; Vasodilator Agents | 1991 |